ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,032, issued on Nov. 3, was assigned to The Council of the Queensland Institute of Medical Research (Herston, Australia).

"Adoptive immunotherapy" was invented by Rajiv Khanna (Brisbane, Australia) and Debottam Sinha (Brisbane, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is the use of a first population of allogeneic T-cells recognizing a first EBV epitope, and a second allogenic population recognizing a second EBV epitope in the treatment of EBV-associated disorders. Also disclosed is the use of a population of allogeneic T-cells recognizing an EBV antigen in combination with a further therapeutic agent such as an immunot...